Finance

Germany's Merck KGaA in $3.9 billion deal to buy US biotech firm SpringWorks

Apr 28, 2025 - 10:16
 0
Germany's Merck KGaA in $3.9 billion deal to buy US biotech firm SpringWorks
Read More

Tags:

Previous Article

National Grid files three-year rate plan for upstate New York

Next Article

Treasury to Raise Forecast for Government Borrowing, Strategists Predict

Related Posts

Is Deutsche Telekom AG (DTE.DE) the Best German Dividend Stock To Buy Now?

Is Deutsche Telekom AG (DTE.DE) the Best German Dividen...

Apr 27, 2025  0

Investment Bank Believes That Palantir (PLTR) Stock Is “Likely” to Retest Highs

Investment Bank Believes That Palantir (PLTR) Stock Is ...

Apr 28, 2025  0

Is enGene Holdings Inc. (ENGN) the Best Canadian Penny Stock to Invest in Now?

Is enGene Holdings Inc. (ENGN) the Best Canadian Penny ...

Apr 25, 2025  0